MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria
There has been a lack of estimates for the incidence/prevalence and treatment patterns of MPNs in many regions of the world, including countries from South Asia, Asia Pacific, Middle East, and Turkey, leading to a difficulty in estimating the true disease burden. Hence, there is a need to establish databases like registries, which would provide information on the “real‐world” data in these regions
